Business Context and Reporting Period
Company: Church & Dwight Co., Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2004
Business Overview: The Company develops, manufactures, and markets household, personal care, and specialty products under brands such as ARM & HAMMER and TROJAN. Operations are divided into three segments: Consumer Domestic (74% of sales), Consumer International (12%), and Specialty Products (14%).
Key Financial Metrics
| Metric | 2004 | 2003 |
|---|---|---|
| Net Sales | $1,462.1 million | $1,056.9 million |
| Gross Profit | $533.4 million | $318.0 million |
| Gross Margin | 36.5% | 30.1% |
| Income from Operations | $171.8 million | $111.9 million |
| Net Income | $88.8 million | $81.0 million |
| Diluted EPS | $1.36 | $1.28 |
| Operating Cash Flow | $194.9 million | $117.9 million |
| Total Debt | $858.7 million | $397.0 million |
| Cash and Equivalents | $145.5 million | $75.6 million |
| Net Debt | $713.2 million | $321.4 million |
Material Changes vs. Prior Period
- Acquisitions: The primary driver of growth was the May 28, 2004, acquisition of the remaining 50% interest in Armkel, LLC (contributing $380.4 million in sales), and the full-year impact of the Unilever oral care business acquired in late 2003.
- Revenue Growth: Net sales increased 38.3% year-over-year, driven by acquisitions, favorable foreign exchange rates ($4.6 million), and a $10.2 million reversal of prior-year promotion reserves.
- Margin Expansion: Gross margin improved to 36.5% from 30.1%, attributed to the higher-margin acquired product lines, partially offset by $10.5 million in inventory purchase accounting charges and $1.5 million in plant impairment charges.
- Expense Increases: Marketing expenses rose 81% ($161.2 million) and SG&A expenses rose 41% ($200.5 million), largely due to the consolidation of Armkel and oral care brands.
- Debt Load: Total debt more than doubled to $858.7 million to finance the Armkel acquisition and refinance existing obligations. This included a $22.9 million charge for the early extinguishment of debt.
Guidance, Outlook, and Risks
- Outlook: Management expects continued growth through new product introductions (e.g., ARM & HAMMER ENAMEL CARE, TROJAN MINT TINGLE) and cost reduction programs. The Company anticipates maintaining dividend payments despite debt covenants.
- Key Risks:
- Customer Concentration: Wal-Mart accounted for approximately 18% of net sales in 2004; the top three customers accounted for 26%.
- Regulatory: Potential FDA restrictions on the spermicide N-9 in TROJAN condoms could impact sales and require labeling changes.
- Competition: Intense competition in mature markets (laundry, oral care) may require increased promotional spending and price concessions, pressuring margins.
- Raw Materials: Increases in costs for surfactants, packaging, and energy could erode profitability if not passed to consumers.
- Debt Service: High indebtedness limits borrowing capacity and increases vulnerability to economic downturns or interest rate hikes.
- Unusual Items: The 2004 results included a $22.9 million loss on early extinguishment of debt and $6.7 million in impairment charges (tradename, plant, and equipment).
Investor Verification Checklist
- Verify the integration progress and performance of the Armkel and Unilever oral care acquisitions against pro forma expectations.
- Monitor the outcome of FDA reviews regarding N-9 in condoms and potential impact on the TROJAN brand.
- Assess the Company's ability to maintain gross margins amidst rising raw material costs and competitive pricing pressure from major retailers like Wal-Mart.
- Review debt covenant compliance, specifically the leverage ratio (Total Debt to Adjusted EBITDA), which was 2.96x in 2004 (limit 4.25x).
- Confirm the success of new product launches (e.g., ENAMEL CARE toothpaste) in driving organic growth beyond acquisition impacts.